Fulgent Genetics, Inc. (FLGT)
17.38
+0.97
(+5.91%)
USD |
NASDAQ |
May 21, 16:00
17.38
0.00 (0.00%)
After-Hours: 19:45
Fulgent Genetics Research and Development Expense (TTM) : 55.69M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Quest Diagnostics, Inc. | -- |
| Labcorp Holdings, Inc. | -- |
| Psychemedics Corp. | -- |
| Guardant Health, Inc. | 366.71M |
| Castle Biosciences, Inc. | 53.30M |